HolderBook

REDHILL BIOPHARMA LTD (RDHL)

Institutional ownership reported to the SEC as of Q2 2026, across 26 quarters.

15
Reporting holders
$270.1K
Reported value
0.0%
Of shares outstanding
0.0%
Held as options
+0
Holder change

Institutions report 315,868 shares against 50,923,261,000 outstanding. Shares only - option lines are excluded, which is why this can be compared with the company at all. The count comes from the cover page of the company's own most recent report, so it is dated when that was filed rather than at quarter end. Share count carried from an earlier filing (cy2025q4i).

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
Yorkville Advisors Global, LP$106.7K122,1310.12%3q-65.2%-$199.8K
GAGNON SECURITIES LLC$74.7K88,4050.01%4qHELD
CITADEL ADVISORS LLC$55.2K65,3210.00%3q+216.0%+$37.7K
RHUMBLINE ADVISERS$11.6K13,7550.00%8q+168.9%+$7.3K
Lido Advisors, LLC$9.3K11,0090.00%newNEW
GAMMA Investing LLC$5.9K6,9570.00%7q+4.1%
CITIGROUP INC$3.7K4,3780.00%newNEW
Federation des caisses Desjardins du Quebec$2.9K3,3880.00%8qHELD
UBS Group AG$851000.00%8q-87.9%
MERCER GLOBAL ADVISORS INC /ADV$42500.00%newNEW
SBI Securities Co., Ltd.$13150.00%7q+275.0%
Smartleaf Asset Management LLC$450.00%3qHELD
Vermillion Wealth Management, Inc.$220.00%7qHELD
MORGAN STANLEY$110.00%8qHELD
ROYAL BANK OF CANADA$03510.00%newNEW

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q2 202615$270.1K315,8684420.0%
Q1 202615$386.5K518,6563510.0%
Q4 202516$514.5K499,4753330.0%
Q3 202513$51.2K23,5844040.0%
Q2 202511$37.9K19,5401430.0%
Q1 202511$80.5K30,2512330.0%
Q4 202410$103.5K16,6791310.0%
Q3 20249$48.8K5,5819000.0%
Q1 20231$770200100.0%
Q4 20222$3530000100.0%
Q3 20222$39.0K0100100.0%
Q2 20222$14.0K0000100.0%
Q1 20222$95.0K0000100.0%
Q4 20212$348.0K0000100.0%
Q3 20212$1.7M0000100.0%
Q2 20213$1.2M0100100.0%
Q1 20212$1.6M0200100.0%
Q4 20201$288.0K0000100.0%
Q3 20201$182.0K0000100.0%
Q2 20202$151.0K0000100.0%
Q1 20202$109.0K0000100.0%
Q4 20192$284.0K0100100.0%
Q3 20192$235.0K0200100.0%
Q2 20191$26.0K0000100.0%
Q1 20192$85.0K0100100.0%
Q4 20182$53.0K0000100.0%